Biogen

The FDA has approved a novel treatment for Lou Gehrig's disease, a rare form of Amyotrophic Lateral Sclerosis (ALS). The injectable medicine is now available for individuals with a rare mutation that accounts for less than 500 cases of…

The Food and Drug Administration's independent panel of experts decided on Wednesday against Biogen's ALS treatment efficacy. ALS medication is under consideration for a rare and aggressive type of illness. Tofersen is a medication that…